Search

everythinglearnresearchcommunity

for

Search:↓

Trichotillomania is more common than previously thought, with increasing diagnosed cases.

Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.

Alopecia areata treatment varies, with no optimal method established yet.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Finasteride might affect memory by impacting cholinergic system.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

New cytokine-targeted therapies show promise for treating alopecia areata.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

A cosmetic procedure can lower the hairline by up to 10 cm, with high satisfaction but potential for temporary sensation loss and rare risks.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Essential oils in cosmetics can offer benefits but may cause allergies and should be used carefully.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Microsurgical reconstruction effectively covers complex scalp defects but doesn't improve survival for cancer-related cases.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Researchers developed a cost-effective 66 K SNP chip for cashmere goats that is accurate and useful for genetic studies.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Over 150 new molecules with biological activities were found in traditional herbal medicines, some with potential for new drug development.

Ruxolitinib treatment may cause eyelash growth.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Citrullus colocynthis and Citrullus lanatus have potential health benefits but may also cause reproductive toxicity.

The document reviews key historical figures and discoveries in dermatology.